🇺🇸 FDA
Pipeline program

AT-777

AT-01C-001

Phase 2 small_molecule terminated

Quick answer

AT-777 for Hepatitis C is a Phase 2 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Atea Pharmaceuticals
Indication
Hepatitis C
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials